Archive - CGH Spotlight Blog
- 2017 Embassy Science Fellowship: Bangkok, Thailand
The Embassy Science Fellow (ESF) program provides U.S. embassies access to the expertise of U.S. government officers in science and technology fields. U.S. embassies request Fellows to assist on science, technology, environment or health issues and related policy development and collaboration.
- New Lancet Oncology publication - Defining a research and policy agenda for betel quid and areca nut
Betel quid and areca nut, typically made up of a mixture of areca nut and slaked lime wrapped in a betel leaf with added flavorings, is a known risk factor for many oral and other associated cancers. There are more than 600 million betel quid or areca nut users worldwide (or 10% of the world’s population), making it a critical global cancer control issue. With its use steeped in culture and tradition, the use of betel quid and areca nut is widely unregulated, and poses a significant and understudied health threat to the Asia-Pacific region where prevalence is high. Unlike many forms of smoked tobacco, the two are widely used by women in regions where common. Betel quid and areca use also extends beyond the Asia-Pacific region to diaspora and migrant communities in the U.S., South Africa, and parts of Europe and the Middle East.
- Engaging Brazilian Partners in Collaborative Cancer Research
CGH engages with Brazilian partners to further collaborative cancer research projects.
- HIV and Cancer Interaction Highlights Need to Address Disease Stigma
The global landscape of disease highlights disparities that exist between nations. An estimated 36 million people worldwide live with HIV and AIDS, of which only 1 million are located within the United States. While the diagnosis of a life-threatening disease can be devastating, individuals with HIV and AIDS frequently bear an additional burden of stigma and discrimination.
- Addressing the Global Burden of Breast Cancer
The US National Cancer Institute’s Center for Global Health (CGH) has been a key partner in a multi-institutional expert team that has developed a set of publications to address foundational concerns in breast cancer care across the cancer care continuum and within limited resource settings.